Computational models of atrial fibrillation: Achievements, challenges, and perspectives for improving clinical care

J Heijman, H Sutanto, HJGM Crijns… - Cardiovascular …, 2021 - academic.oup.com
Despite significant advances in its detection, understanding and management, atrial
fibrillation (AF) remains a highly prevalent cardiac arrhythmia with a major impact on …

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic …

R Noviyani, S Youngkong, S Nathisuwan… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

[HTML][HTML] Coumarin derivatives inhibit ADP-induced platelet activation and aggregation

PH Lu, TH Liao, YH Chen, YL Hsu, CY Kuo, CC Chan… - Molecules, 2022 - mdpi.com
Coumarin was first discovered in Tonka bean and then widely in other plants. Coumarin has
an anticoagulant effect, and its derivative, warfarin, is a vitamin K analogue that inhibits the …

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review

O Keskin, N Farzan, E Birben, H Akel… - Clinical and …, 2019 - Wiley Online Library
There is wide variability in the response to inhaled corticosteroids (ICS) in asthma. While
some of this heterogeneity of response is due to adherence and environmental causes …

Cost‐effectiveness of digital mammography screening before the age of 50 in T he N etherlands

VDV Sankatsing, EAM Heijnsdijk… - … journal of cancer, 2015 - Wiley Online Library
In the Netherlands, routine mammography screening starts at age 50. This starting age may
have to be reconsidered because of the increasing breast cancer incidence among women …

[HTML][HTML] Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle-and High-Income Countries: A Systematic Review

C Okafor, J Byrnes, S Stewart, P Scuffham… - …, 2023 - Springer
Background Atrial fibrillation (AF) remains the most common form of cardiac arrhythmia.
Management of AF aims to reduce the risk of stroke, heart failure and premature mortality via …

Cost‐effectiveness of anticoagulants for preventing stroke in patients with non‐valvular atrial fibrillation in mainland China

H Zhou, X Nie, M Jiang, W Dong - Journal of Clinical Pharmacy …, 2022 - Wiley Online Library
What is known and objective With the high cost, the long‐term persistence of new oral
anticoagulants (NOACs) was lower than that of warfarin in Chinese patients with non …

[HTML][HTML] Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

LA de Jong, J Groeneveld, J Stevanovic, H Rila… - PLoS …, 2019 - journals.plos.org
Introduction Randomized clinical trials (RCTs) and real-world data (RWD) in patients with
atrial fibrillation have shown that—compared to vitamin K antagonists (VKAs)—non-VKA oral …

Trends in direct oral anticoagulant (DOAC) use: health benefits and patient preference

LA De Jong, M Koops, JJ Gout-Zwart… - … Journal of Medicine, 2018 - research.rug.nl
Abstract In 2012, the Dutch Health Council published a report addressing barriers for an
early and broad introduction of direct oral anticoagulants (DOACs). The report raised …

[HTML][HTML] A systematic literature review on the cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation

C Pinyol, JM Cepeda, I Roldan, V Roldan… - Cardiology and …, 2016 - Springer
Introduction Economic evaluations are becoming increasingly important due to limitations in
economic resources, the expense of many new treatments, the need to allocate health …